newsfilter
← Latest News
FDA Approved Drugs·

Approval of Lifyorlitm, Nda #220641 (Type 1 - New Molecular Entity)

Approval Date: 03/25/2026; Drug Name: Lifyorlitm, Nda #220641; Active Ingredients: RELACORILANT; Company: Corcept Therap; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 220641

Company
CORCEPT THERAP
Keywords
CORCEPT THERAP